MwanzoRLF • SWX
add
RELIEF THERAPEUTICS Holding SA
Bei iliyotangulia
CHF 2.36
Bei za siku
CHF 2.31 - CHF 2.49
Bei za mwaka
CHF 1.06 - CHF 7.60
Thamani ya kampuni katika soko
34.89M CHF
Wastani wa hisa zilizouzwa
elfu 26.15
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
SWX
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CHF) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 1.38M | -8.21% |
Matumizi ya uendeshaji wa biashara | 2.63M | -48.44% |
Mapato halisi | -6.28M | 69.86% |
Kiwango cha faida halisi | -454.65 | 67.17% |
Mapato kwa kila hisa | — | — |
EBITDA | -1.45M | 58.14% |
Asilimia ya kodi ya mapato | 18.21% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CHF) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 15.08M | 3.54% |
Jumla ya mali | 53.22M | -30.33% |
Jumla ya dhima | 16.56M | -31.46% |
Jumla ya hisa | 36.66M | — |
hisa zilizosalia | 12.54M | — |
Uwiano wa bei na thamani | 0.81 | — |
Faida inayotokana na mali | -7.07% | — |
Faida inayotokana mtaji | -9.70% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CHF) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -6.28M | 69.86% |
Pesa kutokana na shughuli | elfu 125.00 | 103.50% |
Pesa kutokana na uwekezaji | 2.20M | -50.56% |
Pesa kutokana na ufadhili | elfu -123.00 | -98.39% |
Mabadiliko halisi ya pesa taslimu | 2.18M | 146.71% |
Mtiririko huru wa pesa | 1.25M | -47.41% |
Kuhusu
Relief Therapeutics is a Swiss biopharmaceutical company based in Geneva. The company focuses on developing drugs for serious diseases with few or no existing treatment options. Its lead compound, RLF-100, is a synthetic form of a natural peptide that protects the lung. The company was incorporated as Relief Therapeutics Holdings AG and listed on the SIX Swiss Exchange in 2016. Wikipedia
Ilianzishwa
2013
Tovuti
Wafanyakazi
31
